AhR	aryl hydrocarbon receptors
ALL	acute lymphoblastic leukemia
allo HCT	allogeneic hematopoietic cell transplantation
CAR	Chimeric antigen receptor
CD3ζ	cluster of differentiation 3 zeta-chain
CEA	carcinoembryonic antigen
CNS	central nervous system
CRS	cytokine release syndrome
CTLA-4	cytotoxic T lymphocyte-associated protein 4
DLBCL	diffuse large B cell lymphoma
EGFR	epidermal growth factor receptor
EMA	European Medicines Agency
ERBB2	Erb-B2 receptor tyrosine kinase 2
FAP	fibroblast activation protein
FDA	U.S. Food and Drug Administration
FMT	fecal microbiota transplantation
G2	diganglioside
GVDH	graft-versus-host disease
Her2	human epidermal growth factor receptor 2
ICANS	immune effector cell-associated neurotoxicity syndrome
IFN-γ	interferon gamma
IL	interleukin
IL-13Rα	interleukin 13 receptor α
L1CAM	L1 cell adhesion molecule
LEfSe	linear discriminant analysis effect size
LPS	lipopolysaccharide
MM	multiple myeloma
MUC1	mucin 1
NHL	non-Hodgkin lymphoma
PD-1	programmed cell death protein 1
PSMA	prostate-specific membrane antigen
ROR1	receptor tyrosine kinase-like orphan 1
SCFA	short chain fatty acids
scFv	single-chain variable fragment
TCR	T cell receptors
TNF-α	tumor necrosis factor alpha
TRUCK	T cells redirected for universal cytokine-mediated killing